Variable | Total cases | Three-port LRC (n = 30) | Five-port LRC (n = 54) | P value |
---|---|---|---|---|
Age, [years, mean ± SD] | 69.31 ± 9.36 | 70.84 ± 9.89 | 68.44 ± 9.03 | 0.258 |
Gender, [cases (%)] | 0.093 | |||
Male | 64 (76.2) | 26 (86.50) | 38 (70.40) | |
Female | 20 (23.8) | 4 (13.50) | 16 (29.60) | |
Smoking status, [cases (%)] | 0.090 | |||
Yes | 40 (47.62) | 18 (60.00) | 22 (40.74) | |
No | 44 (52.38) | 12 (40.00) | 32 (59..26) | |
Diabetes mellitus, [cases (%)] | 1.00 | |||
Yes | 14 (16.67) | 5 (16.67) | 9 (16.67) | |
No | 70 (83.33) | 25 (83.33) | 45 (83.33) | |
Hypertension, [cases (%)] | 0.461 | |||
Yes | 32 (38.10) | 13 (43.33) | 19 (35.19) | |
No | 52 (61.90) | 17 (56.67) | 35 (64.81) | |
Previous abdominal surgery*, [cases (%)] | 0.080 | |||
Yes | 19 (22.62) | 10 (33.33) | 9 (16.67) | |
No | 65 (77.38) | 20 (66.67) | 45 (83.33) | |
Previous TURBT, [cases (%)] | 0.973 | |||
Yes | 31 (36.90) | 11 (36.67) | 20 (37.04) | |
No | 53 (63.10) | 19 (63.33) | 34 (62.96) | |
Previous chemotherapy, [cases (%)] | 0.398 | |||
Yes | 26 (30.95) | 11 (36.67) | 15 (27.78) | |
No | 58 (59.05) | 19 (63.33) | 39 (72.22) | |
BMI, [kg/m2,mean ± SD] | 22.77 ± 3.03 | 22.36 ± 3.04 | 23.00 ± 3.03 | 0.359 |
ASA score, [cases (%)] | 0.471 | |||
≤ 2 | 60 (71.43) | 20 (66.67) | 40 (74.07) | |
> 2 | 24 (28.57) | 10 (33.33) | 14 (25.93) | |
Preoperative hydronephrosis,[cases (%)] | 0.399 | |||
Yes | 13 (15.48) | 6 (20.00) | 7 (12.96) | |
No | 71 (84.52) | 24 (80.00) | 47 (87.04) | |
Clinical tumour stage, [cases (%)] | 0.609 | |||
≤ T1 | 28 (33.33) | 8 (26.67) | 20 (37.04) | |
T2 | 32 (38.10) | 13 (43.33) | 19 (35.18) | |
T3-4 | 24 (28.57) | 9 (30.00) | 15 (27.78) | |
Preoperative creatinine, [umol/L, median (range)] | 80 (49.00–143.50) | 84 (39.00–143.50) | 78 (44.00–135.00) | 0.307 |